Kenneth Yip

Assistant Professor, Teaching Stream

University of Toronto

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Kenneth Yip is an Assistant Professor in the Teaching Stream at the University of Toronto, Canada. His research areas include molecular pathogenesis and clinical manifestations of radiation fibrosis, cancer biomarkers, and therapeutic strategies for cancer treatment. Recent publications highlight his work on nasopharyngeal carcinoma, breast cancer-related lymphedema, and the role of inflammatory biomarkers in cancer prognosis.

Articles (9)

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Eugene Chang

Assistant Professor

University of Toronto

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kenneth Yip

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

The clinical manifestations and molecular pathogenesis of radiation fibrosis

CD8+ Tumor-Infiltrating Lymphocyte Abundance Is a Positive Prognostic Indicator in Nasopharyngeal Cancer.

Editorial: Hallmark of cancer: Resisting cell death.

COPA Syndrome (Ala239Pro) Presenting with Isolated Follicular Bronchiolitis in Early Childhood: Case Report.

miRNA biomarkers for NPC diagnosis and prognosis

Development and Validation of a Risk Model for Breast Cancer-Related Lymphedema.

MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.

Inflammatory Biomarkers, Hematopoietic Stem Cells, and Symptoms in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy.

Targeting metabolic dysregulation for fibrosis therapy

Collaborators (1)

Eugene Chang

Make your next move.